Apple Accuses AliveCor of ‘Brazen’ Patent Infringement in Unusual Countersuit


Apple right this moment time filed a patent infringement lawsuit in opposition to AliveCor, a company that has developed the ECG “KardiaBand” designed for the Apple See, among comparatively about a ECG-centered merchandise. AliveCor and Apple are already within the course of a steady wrestle following an ITC criticism and antitrust lawsuit that AliveCor filed closing One year

In accordance with Apple, AliveCor’s product line has now not been winning with possibilities, and the corporate’s “failures available within the market” possess led it to “opportunistic assertions of its patents in opposition to Apple.” Earlier this One year, AliveCor submitted an World Substitute Payment criticism in opposition to Apple in an strive to safe an import ban on the Apple See, and the raise ruled in AliveCor’s desire.

Apple says that while it’s some distance attention-grabbing the ruling, it’s some distance using this new patent infringement submitting to “achieve of residing the file straight as to who is the accurate pioneer,” striking a discontinue to AliveCor’s “rampant infringement that unlawfully appropriates Apple’s mental property.” From the submitting:

Apple is the pioneering innovator, having researched, developed, and patented core, foundational applied sciences sooner than AliveCor came into existence. AliveCor’s litigation marketing and marketing campaign is nothing more than an strive to siphon from the success of Apple applied sciences it did now not safe, your complete while selling merchandise that count on foundational ECG innovations that Apple patented years sooner than AliveCor came to be.

The criticism cites several Apple patents linked to the coronary heart rate and ECG functionality within the Apple See, which Apple says AliveCor’s KardiaMobile, KardiaMobile Card, and Kardia app infringe on.

Apple claims that AliveCor’s patent infringements are inflicting Apple irreparable hurt, with Apple aiming for a eternal injunction to discontinue additional infringement, as successfully as damages and steady charges.

AliveCor first filed an antitrust swimsuit in opposition to Apple aid in Would possibly per chance presumably well additionally 2021, accusing Apple of “monopolistic conduct” for the launch of the ECG functionality within the Apple See. AliveCor claims that Apple seen the success of its KardiaBand and determined to “corner the market for coronary heart rate prognosis on Apple See.”

The company has also filed patent infringement complaints accusing Apple of coping AliveCor’s cardiological detection and prognosis technology.

Apple’s paunchy criticism in opposition to AliveCor can also merely additionally be be taught on Scribd.

This article, “Apple Accuses AliveCor of ‘Brazen’ Patent Infringement in Unusual Countersuit” first regarded on MacRumors.com

Discuss this text in our forums